IP Library Granted Patent US 9,040,665
Granted Patent B2
US 9,040,665 · App. 13/430,562 · Granted May 26, 2015

Controlled cross-linking processing of proteins

Inventors: Gary Wnek (Cleveland, OH); Linghui Meng (Framingham, MA)
Assignee: Case Western Reserve University
C07K1/36C07K1/107C07K1/1075A61L27/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,665
App. No.
13/430,562
Granted
May 26, 2015
Kind
B2
Abstract

A method of forming a cross-linked protein structures includes preparing a solution of protein dissolved in a benign solvent and forming an intermediate protein structure from the solution. The intermediate protein structure can be cross-linked by providing for a specific ratio of chemical cross-linking agents to form the cross-linked protein structure. The solution can be prepared by adding a cross-linker of N-hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) at a ratio of two-to-one of NHS to EDC to alcohol. PBS buffer (20×) can be added to the solution until the volume ratio of PBS buffer (20×) to alcohol is about one-to-one. About 16 percent by weight of protein can be dissolved in the solution. The solution can be electrospun to form an intermediate protein structure. After a period of time, the protein structure can be cross-linked to form the cross-linked protein structure.

Claims (17)

1. A method of forming a cross-linked protein structure, comprising:

forming a protein solution by dissolving a protein in a solution of water, salt, alcohol, and a cross-linker, wherein the cross-linker is N-hydroxysuccinimide (“EDC”) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (“NHS”), and the protein is collagen;

forming an intermediate protein structure from the protein solution; and

after a period of time has elapsed, cross-linking at least a portion the intermediate protein structure to form the cross-linked protein structure.

2. The method of claim 1 , wherein the molar ratio of NHS to EDC is about 1:1.

3. The method of claim 1 , wherein the intermediate protein structure is formed by an electrospinning process.

4. The method of claim 1 , wherein the intermediate protein structure is formed by an electrospraying process.

5. The method of claim 1 , wherein the intermediate protein structure is formed by a gravitational feed process.

6. The method of claim 1 , wherein the collagen dissolved in the solution is less than about 25 percent by weight.

7. The method of claim 6 , wherein the collagen dissolved in the solution is about 16 percent by weight.

8. The method of claim 1 , wherein the cross-linker is EDC and NHS, and the protein is gelatin.

9. The method of claim 8 , wherein the molar ratio of NHS to EDC is 1:1.

10. The method of claim 8 , wherein the intermediate protein structure is formed by an electrospinning process.

11. The method of claim 8 , wherein the intermediate protein structure is formed by an electrospraying process.

12. The method of claim 8 , wherein the intermediate protein structure is formed by a gravitational feed process.

13. The method of claim 8 , wherein the gelatin dissolved in the solution is less than about 25 percent by weight.

14. The method of claim 13 , wherein the gelatin dissolved in the solution is about 16 percent by weight.

Continuity (4)
Continuation In Part 12571043 · Sep 30, 2009
Provisional Application 61194685 · Sep 30, 2008
Provisional Application 61467923 · Mar 25, 2011
Related Publication 20130023648A1 · Jan 24, 2013